"general ophthalmology/eye care with a focus on cataracts,cornea, cornea transplants,dry eye and keratoconus"

During the past decade, Bay Area Eye Institute conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Bay Area Eye Institute" are "Corneal Ulcer" (2 trials) and "Keratitis" (2 trials). Many other conditions were trialed in "Bay Area Eye Institute" in a lesser frequency.

Most popular intervention types in "Bay Area Eye Institute" are "Combination Product" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "PXL Platinum 330 system + Riboflavin 0.25% TE Solution" (1 trials), "Sham CXL + Artificial Tears" (1 trials), "Standard of Care Therapy + CXL + Riboflavin 0.23% L Solution" (1 trials) and "Standard of Care Therapy + Sham CXL + Artificial Tears" (1 trials). Other intervention names were less common.

The vast majority of trials in "Bay Area Eye Institute" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Bay Area Eye Institute". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Bay Area Eye Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Bay Area Eye Institute, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".